42
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Gelatin‐polysaccharide composite scaffolds for 3D cell culture and tissue engineering: Towards natural therapeutics

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Gelatin is a promising material as scaffold with therapeutic and regenerative characteristics due to its chemical similarities to the extracellular matrix (ECM) in the native tissues, biocompatibility, biodegradability, low antigenicity, cost‐effectiveness, abundance, and accessible functional groups that allow facile chemical modifications with other biomaterials or biomolecules. Despite the advantages of gelatin, poor mechanical properties, sensitivity to enzymatic degradation, high viscosity, and reduced solubility in concentrated aqueous media have limited its applications and encouraged the development of gelatin‐based composite hydrogels. The drawbacks of gelatin may be surmounted by synergistically combining it with a wide range of polysaccharides. The addition of polysaccharides to gelatin is advantageous in mimicking the ECM, which largely contains proteoglycans or glycoproteins. Moreover, gelatin–polysaccharide biomaterials benefit from mechanical resilience, high stability, low thermal expansion, improved hydrophilicity, biocompatibility, antimicrobial and anti‐inflammatory properties, and wound healing potential. Here, we discuss how combining gelatin and polysaccharides provides a promising approach for developing superior therapeutic biomaterials. We review gelatin–polysaccharides scaffolds and their applications in cell culture and tissue engineering, providing an outlook for the future of this family of biomaterials as advanced natural therapeutics.

          Related collections

          Most cited references226

          • Record: found
          • Abstract: not found
          • Article: not found

          Hydrogels for tissue engineering.

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Hydrogels in Biology and Medicine: From Molecular Principles to Bionanotechnology

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Hydrogels in regenerative medicine.

              Hydrogels, due to their unique biocompatibility, flexible methods of synthesis, range of constituents, and desirable physical characteristics, have been the material of choice for many applications in regenerative medicine. They can serve as scaffolds that provide structural integrity to tissue constructs, control drug and protein delivery to tissues and cultures, and serve as adhesives or barriers between tissue and material surfaces. In this work, the properties of hydrogels that are important for tissue engineering applications and the inherent material design constraints and challenges are discussed. Recent research involving several different hydrogels polymerized from a variety of synthetic and natural monomers using typical and novel synthetic methods are highlighted. Finally, special attention is given to the microfabrication techniques that are currently resulting in important advances in the field.
                Bookmark

                Author and article information

                Contributors
                khademh@ucla.edu
                Journal
                Bioeng Transl Med
                Bioeng Transl Med
                10.1002/(ISSN)2380-6761
                BTM2
                Bioengineering & Translational Medicine
                John Wiley & Sons, Inc. (Hoboken, USA )
                2380-6761
                28 December 2018
                January 2019
                : 4
                : 1 ( doiID: 10.1002/btm2.v4.1 )
                : 96-115
                Affiliations
                [ 1 ] Biomaterials Innovation Research Center, Division of Biomedical Engineering, Dept. of Medicine Brigham and Women's Hospital, Harvard Medical School Cambridge MA 02142
                [ 2 ] Harvard‐MIT Division of Health Sciences and Technology Massachusetts Institute of Technology Cambridge MA 02139
                [ 3 ] Center for Minimally Invasive Therapeutics (C‐MIT) University of California‐Los Angeles Los Angeles CA 90095
                [ 4 ] California NanoSystems Institute (CNSI) University of California‐Los Angeles Los Angeles CA 90095
                [ 5 ] Dept. of Bioengineering University of California‐Los Angeles Los Angeles CA 90095
                [ 6 ] Nanomedicine Division, Dept. of Zoology Periyar University Salem Tamil Nadu India
                [ 7 ] Dept. of Radiological Sciences, David Geffen School of Medicine University of California‐Los Angeles Los Angeles CA 90095
                [ 8 ] Dept. of Chemical and Biomolecular Engineering University of California‐Los Angeles Los Angeles CA 90095
                [ 9 ] Dept. of Bioindustrial Technologies, College of Animal Bioscience and Technology Konkuk University Seoul Republic of Korea
                Author notes
                [*] [* ] Correspondence

                Prof. Ali Khademhosseini, Center for Minimally Invasive Therapeutics (C‐MIT), University of California ‐ Los Angeles, Los Angeles, CA 90095.

                Email: khademh@ 123456ucla.edu .

                [†]

                These authors contributed equally to this study.

                Article
                BTM210124
                10.1002/btm2.10124
                6336672
                30680322
                141ca3e6-96d8-4748-845d-773a3a319def
                © 2018 The Authors. Bioengineering & Translational Medicine published by Wiley Periodicals, Inc. on behalf of The American Institute of Chemical Engineers.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 26 September 2018
                : 23 November 2018
                : 26 November 2018
                Page count
                Figures: 6, Tables: 1, Pages: 20, Words: 19109
                Funding
                Funded by: National Institutes of Health
                Award ID: AR057837
                Award ID: AR066193
                Award ID: EB021857
                Award ID: HL137193
                Award ID: CA214411
                Award ID: EB023052
                Award ID: HL140618
                Award ID: GM126831
                Award ID: HL140951
                Award ID: AR073135
                Award ID: AR069564
                Funded by: University Grants Commission
                Funded by: Sweden‐America Foundation (The family Mix Entrepreneur foundation)
                Funded by: Canadian Institutes of Health Research (CIHR)
                Categories
                Review
                Reviews
                Custom metadata
                2.0
                btm210124
                January 2019
                Converter:WILEY_ML3GV2_TO_NLMPMC version:5.5.6 mode:remove_FC converted:17.01.2019

                3d cell culture,gelatin,polysaccharides,scaffold,therapeutics,tissue engineering

                Comments

                Comment on this article